The IsoPet® Solutions division is focused on bringing RadioGel™ yttrium-90 brachytherapy products to veterinary oncologists to treat dogs and cats suffering
from tumor cancers.
There are over 150 million pet dogs and cats, with over 1/3 of the households in the US owning at least one dog, and just under 1/3 owning at least one cat.
IsoPet® Solutions is establishing the infrastructure necessary to provide product to veterinary clinics including regulatory clearances and compliance. The division will also provide product
awareness and education to veterinary oncologists.
Initial treatments were coordinated through the Chair of the Company’s Veterinary Medicine Advisory Board, Dr. Alice